Robert N. Fried
Net Worth
Last updated:
What is Robert N. Fried net worth?
The estimated net worth of Mr. Robert N. Fried is at least $8,047,968 as of 31 May 2023. He owns shares worth $749,159 as insider, has earned $6,379 from insider trading and has received compensation worth at least $7,292,430 in ChromaDex Corporation.
What is the salary of Robert N. Fried?
Mr. Robert N. Fried salary is $810,270 per year as Chief Executive Officer & Director in ChromaDex Corporation.
How old is Robert N. Fried?
Mr. Robert N. Fried is 65 years old, born in 1960.
What stocks does Robert N. Fried currently own?
As insider, Mr. Robert N. Fried owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
ChromaDex Corporation (CDXC) | Chief Executive Officer & Director | 95,001 | $7.89 | $749,159 |
What does ChromaDex Corporation do?
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
Robert N. Fried insider trading
ChromaDex Corporation
Mr. Robert N. Fried has made only one insider trade between 2016-2023, according to the Form 4 filled with the SEC. He purchased 7,000 units of CDXC stock worth $9,940 on 31 May 2023.
As of 31 May 2023 he still owns at least 95,001 units of CDXC stock.
ChromaDex key executives
ChromaDex Corporation executives and other stock owners filed with the SEC:
- Mr. Frank Louis Jaksch Jr. (57) Co-Founder & Executive Chairman
- Mr. Kevin M. Farr CPA (67) Chief Financial Officer
- Mr. Robert N. Fried (65) Chief Executive Officer & Director